No Cover Image

Journal article 429 views

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β

Steve Simpson-Yap Orcid Logo, Ashkan Pirmani, Edward De Brouwer, Liesbet M. Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rod Middleton Orcid Logo, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik

Multiple Sclerosis and Related Disorders, Volume: 66, Start page: 104072

Swansea University Author: Rod Middleton Orcid Logo

Full text not available from this repository: check for access using links below.

Published in: Multiple Sclerosis and Related Disorders
ISSN: 2211-0348
Published: Elsevier BV 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa61482
Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: COVID-19; Coronavirus disease of 2019; ICU; Intensive care unit; OROdds ratio; DMT; Disease modifying therapy
College: Faculty of Medicine, Health and Life Sciences
Start Page: 104072